Seth Klarman
Baupost Group
Baupost Group Portfolio 13F
Seth Klarman Holdings Activity
- Portfolio value:
- $8.02B≈ (-$730M≈)
- Previous value:
- $8.75B≈
- # of changes:
- 24
- New positions:
- 5
- Reported for:
- 30 Sep 2017 (Q3)
- Latest filing date:
- 13 Nov 2017
Baupost Group has disclosed a total of 24 changes to the portfolio in the (2017 Q3) SEC report(s): increased the number of shares of 7, bought 5 totally new, decreased the number of shares of 4 and completely sold out 8 position(s).
What stocks did Seth Klarman buy in 2017 Q3?
During 2017 Q3 Seth Klarman has bought 12 securities out of which top 5 purchases (by % change to portfolio) were (AGN) ACTAVIS INC COM STK (NV) (added shares +21.85%), (AR) Antero Resources Corp (added shares +12.95%), (TBPH) THERAVANCE BIOPHARMA INC (added shares +0.38%), (FOX) Fox Corp, CL-B (added shares +1.46%) and (CAH) Cardinal Health Inc (added shares +24.63%).
In the 2017 Q3 report(s) the following change has been made to the top investments: (AGN) ACTAVIS INC COM STK (NV) (added shares +21.85%).
24 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AMC ENTERTAINMENT HLDS, CL-A
|
new
|
$14.70
|
-82.07%($2.64)
|
0.65%
|
2017 Q3
|
≈ 0.25 years
|
||||
|
|
Cencora Inc
|
new
|
$82.75
|
+272.46%($308.20)
|
0.19%
|
2017 Q3
|
≈ 0.25 years
|
||||
|
|
McKesson Corp
|
new
|
$153.61
|
+443.13%($834.30)
|
0.96%
|
2017 Q3
|
≈ 0.25 years
|
||||
|
|
Pioneer Natural Resources Co
|
new
|
$147.53
|
|
0.05%
|
2017 Q3
|
≈ 0.25 years
|
||||
|
|
SIMPLY GOOD FOODS CO-CW22
|
new
|
$2.37
|
|
0.03%
|
2017 Q3
|
≈ 0.25 years
|
||||
|
|
Cardinal Health Inc
|
+24.63%
|
$66.92
|
+251.35%($235.12)
|
2.11%
|
2016 Q4
|
≈ 1.00 year
|
||||
|
|
ACTAVIS INC COM STK (NV)
|
+21.85%
|
$204.95
|
|
7.57%
|
2016 Q1
|
≈ 1.75 years
|
||||
|
|
Antero Resources Corp
|
+12.95%
|
$19.90
|
+79.20%($35.66)
|
5.93%
|
2014 Q3
|
≈ 3.25 years
|
||||
|
|
FORWARD PHARMA A/S-ADR
|
+1.56%
|
$12,139.82
|
|
0.49%
|
2014 Q4
|
≈ 3.00 years
|
||||
|
|
Fox Corp, CL-B
|
+1.46%
|
$25.79
|
+102.52%($52.23)
|
2.37%
|
2015 Q3
|
≈ 2.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.